nobiletin has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakajima, A; Nemoto, K; Ohizumi, Y | 1 |
| Ahmed, T; Behzad, S; Braidy, N; Daglia, M; Habtemariam, S; Nabavi, SF; Nabavi, SM; Sobarzo-Sanchez, E | 1 |
| Nakajima, A; Ohizumi, Y | 1 |
| Choi, IY; Choi, MS; Chu, JW; Jang, MC; Jeon, MT; Jeong, KH; Jung, UJ; Kim, HD; Kim, SR; Yang, SJ | 1 |
2 review(s) available for nobiletin and Parkinson Disease
| Article | Year |
|---|---|
Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
Topics: Alzheimer Disease; Animals; Citrus; Flavones; Flavonoids; Humans; Neuroprotective Agents; Parkinson Disease; Phytotherapy | 2017 |
Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Biomarkers; Citrus; Disease Models, Animal; Drug Evaluation, Preclinical; Flavones; Flavonoids; Humans; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Signal Transduction | 2019 |
2 other study(ies) available for nobiletin and Parkinson Disease
| Article | Year |
|---|---|
An evaluation of the genotoxicity and subchronic toxicity of the peel extract of Ponkan cultivar 'Ohta ponkan' (Citrus reticulata Blanco) that is rich in nobiletin and tangeretin with anti-dementia activity.
Topics: Administration, Oral; Alzheimer Disease; Animals; Body Weight; Chromosome Aberrations; Citrus; Dose-Response Relationship, Drug; Female; Flavones; Functional Food; Male; Micronucleus Tests; Nootropic Agents; Parkinson Disease; Plant Extracts; Plants, Medicinal; Rats; Rats, Sprague-Dawley | 2020 |
Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Disease Models, Animal; Dopaminergic Neurons; Female; Flavones; Glial Cell Line-Derived Neurotrophic Factor; Humans; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2015 |